Patent · US Active

Compounds and methods useful for treating or preventing cancers

US11633415B2 · kind B2 · utility

0Cited by
3References
15Claims
0Family size

Assignees

Inventors

Key dates

Filing dateMar 30, 2018
Grant dateApr 25, 2023
Priority date
Expiry dateNov 8, 2038

Classification

  • Technology area (CPC A)Human Necessities
  • CPC primaryA61K31/498
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

The present invention includes CSNK1A1 inhibitors that are useful in treating or preventing a cancer in a subject. In certain embodiments, the cancer comprises a hematological cancer, such as but not limited to acute myeloid leukemia (AML) and/or MDS (myelodysplastic syndrome, including 5q-MDS). In other embodiments, the cancer comprises colon cancer.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.